Data from 2 studies, LIGHTHOUSE and SPOTLIGHT, have shown the benefit of flotufolastat F 18 injection as a radiohybrid PSMA-targeted PET imaging agent in prostate cancer. The agent has now been added ...
The objective of androgen deprivation therapy (ADT) in men with prostate cancer is to maintain very low levels of testosterone so that the hormone does not promote tumor growth. But a new analysis ...
− Oral presentation highlighted at 2023 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting – MONROE TOWNSHIP, N.J. & OXFORD, England--(BUSINESS WIRE)--Blue Earth Diagnostics, a ...
FDA approves Jevtana injection for prostate cancer Sanofi-aventis announced that the FDA has approved Jevtana (cabazitaxel injection) in combination with prednisone for the treatment of patients with ...
GREENVILLE, SOUTH CAROLINA / ACCESS Newswire / December 9, 2025 / The Longevity Center, an integrative and regenerative health clinic with multiple locations, is now offering targeted ozone prostate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback